300+ investors in your industry, stage, and region Get
Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Wellness
Education
Medical Device
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Medical
Web3
Theatre
Recruiting
Crowdfunding
Infrastructure
Venture Capital
Beauty
Fashion
Social
Celebrity
LGBT
Climate
Cannabis
Wine and Spirits
Mobile Apps
Life Science
Food and Beverage
Publishing
Art
Music
Real Estate
Sporting Goods
FinTech
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Transportation
Biotech
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Brazil
Africa
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Tunisia
Sweden
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Oman
Puerto Rico
Poland
Guernsey
Cameroon
Armenia
Colombia
China
Costa Rica
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Uruguay
Morocco
Moldova
Seychelles
Botswana
Paraguay
South Africa
France
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Bermuda
Asia
Dominican Republic
Albania
Angola
Europe
Cyprus
Spain
Qatar
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Lithuania
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Avançsa, VC Fund

Avançsa

VC Fund

Avançsa is a VC fund focused on Software and Manufacturing. Private equity arm of Generalitat de Catalunya .

Total investments:
21
Last investment:
Lead investor:
71%

Last updated:

Industries Avançsa invests in

SoftwareManufacturingMedical DeviceInformation TechnologyClean Energy

Stages Avançsa invests in

Debt FinancingVenture - Series UnknownSeedSeries ASeries B

Countries Avançsa invests in

Spain

Round sizes

Debt Financing $541k–$2.4MVenture - Series Unknown $2.1M–$8.4M

Round size

Debt Financing
$541k–$2.4M
Venture - Series Unknown
$2.1M–$8.4M

Investment Focus

Industry

  • Software 4 (19%)
  • Manufacturing 3 (14%)
  • Medical Device 3 (14%)
  • Information Technology 3 (14%)
  • Clean Energy 2 (10%)
See all 51 industries →

Stage

  • Debt Financing 12 (57%)
  • Venture - Series Unknown 4 (19%)
  • Seed 1 (5%)
  • Series A 1 (5%)
  • Series B 1 (5%)
See all 7 stages →

Investments

CompanyDescriptionRoundLinks
Floox llega para diseñar, desarrollar y fabricar puntos de carga rápida en corriente continua para vehículos eléctricos. Somos un equipo de más 120 personas trabajando para revolucionar la movilidad eléctrica y así crear un mundo más efectivo, fácil y sostenible. $2.3M / Venture - Series Unknown / Jun 17, 2026
INGALSA specializing in hot-dip galvanizing of steel parts and fasteners. $813.7K / Debt Financing / Nov 14, 2025
NEOS Surgery is a technology-based company dedicated to the creation of medical devices for neurosurgery. The company focuses on the R&D, design, production, and commercialization of innovative implants in the fields of cranial and spinal surgery. Our products aim at occupying the niches of the current market by responding to the needs of bothpatients and neurosurgeons.NEOS is a certified producer of medical devices and implements the complete ISO 9001: 2008 and ISO 13485: 2003 / AC: 2007 quality systems.NEOS Surgery’s mission is to capture the demands of the Neurosurgery market in order to develop, manufacture, certify and commercialize new devices, which create company value and foster a high added-value industry. $582.3K / Debt Financing / Oct 15, 2025
X1 Wind is a disruptive floating platform developing a floating wind platform for deep waters. The platform has redesigned floating wind platforms to reduce costs by 50percent and weight 80percent while expanding the operation depth range in comparison to other floating solutions. It has less active systems than current designs and can be fullyassembled at the port and then installed using a small tug boat.X1 Wind helps to achieve a radical weight reduction in floating wind structures to current semi-submersible and spar systems. It was founded in 2017 and is based in Barcelona, Spain. $641.6K / Convertible Note / Jul 14, 2025
NearbyComputing commercializes NearbyOne, an Edge IT fabrics orchestration platform that seamlessly manages the lifecycle of infrastructure, the VNFs and the applications, controlling their deployment and associated resources. NearbyOne addresses all these orchestration issues in a holistic and intertwined way. Applications and VNFs provided bythird party ISVs are onboarded to create a rich ecosystem of pre-integrated services, that get deployed in one-click. Service assurance and KPI monitoring are natively integrated into the platform to automatically control service SLAs. Infratructure, Network, Apps and KPIs are managed from a single pane of glass, and smart placement and configuration policies dynamically adjust service levels. $559.3K / Debt Financing / May 13, 2025
INBRAIN Neuroelectronics is pioneering real time precision neurology with the world’s first graphene-based brain-computer interface (BCI) therapeutics platform. Our technology combines precise BCI decoding with micrometric modulation to deliver adaptive, personalized treatments for conditions such as Parkinson’s disease, epilepsy, and strokerehabilitation. By providing continuous real-time monitoring and autonomous therapy adjustments, our AI-driven platform maximizes therapeutic outcomes while minimizing side effects. Through strategic collaborations, including with Merck KGAa and our subsidiary INNERVIA Bioelectronics, we are extending our innovative solutions to peripheral nerve and systemic disease applications, unlocking the potential of neurotechnology and bioelectronics. For more information, visit www.inbrain-neuroelectronics.com and follow us on LinkedIn. $49.8M / Series B / Oct 29, 2024
Qilimanjaro is a quantum computing company based in Barcelona, making quantum useful today. Founded in 2019, we develop full-stack quantum computers based on fluxonium analog qubits, a novel architecture that bypasses the need for error correction, enabling faster, more scalable solutions. Our approach is application-first: analog quantum computingoffers near-term advantages and optimality for highly relevant problems, especially in simulation, optimization, and AI, where digital QPUs fall short. We follow a dual strategy to democratize access to quantum computing:• Via our Quantum-as-a-Service (QaaS) platform, users can remotely access our hybrid quantum data centers, combining analog and digital QPUs with classical HPC. • For research institutions and HPC centers, we provide on-premise quantum deployments, offering flexibility, control, and co-design.By aligning quantum hardware with real-world needs, Qilimanjaro is building a future where quantum computing is practical, scalable, and ready to deliver value - not in decades, but now. $1.6M / Debt Financing / Jul 18, 2024
Ocean Ecostructures is the developer of a biodiversity regeneration program that will assist businesses and governments in transitioning to a blue economy. $540.6K / Debt Financing / Jun 12, 2024
visual+cognitive enhancement $4.3M / Series A / Feb 19, 2024
Zymvol accelerates the discovery & development of new industrial enzymes through computer simulations. $761.5K / Debt Financing / Jan 16, 2024
See all 21 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Wellness
Education
Medical Device
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Medical
Web3
Theatre
Recruiting
Crowdfunding
Infrastructure
Venture Capital
Beauty
Fashion
Social
Celebrity
LGBT
Climate
Cannabis
Wine and Spirits
Mobile Apps
Life Science
Food and Beverage
Publishing
Art
Music
Real Estate
Sporting Goods
FinTech
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Transportation
Biotech
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Brazil
Africa
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Tunisia
Sweden
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Oman
Puerto Rico
Poland
Guernsey
Cameroon
Armenia
Colombia
China
Costa Rica
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Uruguay
Morocco
Moldova
Seychelles
Botswana
Paraguay
South Africa
France
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Bermuda
Asia
Dominican Republic
Albania
Angola
Europe
Cyprus
Spain
Qatar
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Lithuania
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Avançsa invest in?

Avançsa invests primarily in Software, Manufacturing and Medical Device startups, most often at Debt Financing and Venture - Series Unknown stage. Most of the 21 investments tracked by Shizune back companies in Spain. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What round sizes does Avançsa invest in?

Avançsa typically joins rounds of $541k–$2.4M at Debt Financing and $2.1M–$8.4M at Venture - Series Unknown. These are whole funding-round sizes, not Avançsa's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Avançsa took part in.

When did Avançsa last invest?

The most recent investment recorded for Avançsa closed in Jun 2026. Shizune tracks 21 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Avançsa Avançsa Find emails